Reuters logo
BRIEF-Rovi starts enoxaparin biosimilar marketing in Germany‍​
September 7, 2017 / 3:57 PM / 12 days ago

BRIEF-Rovi starts enoxaparin biosimilar marketing in Germany‍​

Sept 7 (Reuters) - LABORATORIOS FARMACEUTICOS ROVI SA:

* SAYS STARTS ENOXAPARIN BIOSIMILAR MARKETING IN GERMANY‍​ Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below